Cargando…

Progress in Rare Diseases Research 2010–2016: An IRDiRC Perspective

Detalles Bibliográficos
Autores principales:	Dawkins, Hugh J.S., Draghia‐Akli, Ruxandra, Lasko, Paul, Lau, Lilian P.L., Jonker, Anneliene H., Cutillo, Christine M., Rath, Ana, Boycott, Kym M., Baynam, Gareth, Lochmüller, Hanns, Kaufmann, Petra, Le Cam, Yann, Hivert, Virginie, Austin, Christopher P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759730/ https://www.ncbi.nlm.nih.gov/pubmed/28796411 http://dx.doi.org/10.1111/cts.12501

Ejemplares similares

Future of Rare Diseases Research 2017–2027: An IRDiRC Perspective
por: Austin, Christopher P., et al.
Publicado: (2017)

‘IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases
por: Lochmüller, Hanns, et al.
Publicado: (2017)

The use or generation of biomedical data and existing medicines to discover and establish new treatments for patients with rare diseases – recommendations of the IRDiRC Data Mining and Repurposing Task Force
por: Southall, Noel T, et al.
Publicado: (2019)

The IRDiRC Chrysalis Task Force: making rare disease research attractive to companies
por: Beaverson, Katherine L., et al.
Publicado: (2023)

The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact
por: Lochmüller, Hanns, et al.
Publicado: (2017)

Essential list of medicinal products for rare diseases: recommendations from the IRDiRC Rare Disease Treatment Access Working Group
por: Gahl, William A., et al.
Publicado: (2021)

Recommendations from the IRDiRC Working Group on methodologies to assess the impact of diagnoses and therapies on rare disease patients
por: Zanello, Galliano, et al.
Publicado: (2022)

Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC Task Force
por: Nabbout, Rima, et al.
Publicado: (2023)

Measuring what matters to rare disease patients – reflections on the work by the IRDiRC taskforce on patient-centered outcome measures
por: Morel, Thomas, et al.
Publicado: (2017)

International collaborative actions and transparency to understand, diagnose, and develop therapies for rare diseases
por: Boycott, Kym M, et al.
Publicado: (2019)

Opportunities for vaccine research in Europe
por: Gancberg, David, et al.
Publicado: (2015)

The selection of experts evaluating health projects for the EU Sixth Framework Program
por: Quaglio, GianLuca, et al.
Publicado: (2011)

How to START? Four pillars to optimally begin your orphan drug development
por: Jonker, Anneliene Hechtelt, et al.
Publicado: (2023)

Gene therapy by electroporation for the treatment of chronic renal failure in companion animals
por: Brown, Patricia A, et al.
Publicado: (2009)

Increased immunogenicity of HIV vaccination with constant-current electroporation and molecular adjuvants in mice and rhesus macaques
por: Hirao, Lauren, et al.
Publicado: (2006)

A pan-serotype antiviral to prevent and treat dengue: A journey from discovery to clinical development driven by public-private partnerships
por: Goethals, Olivia, et al.
Publicado: (2023)

Prospective validation of the “rhino conjunctivitis allergy-control-SCORE(©)” (RC-ACS(©))
por: Häfner, Dietrich, et al.
Publicado: (2012)

Heterosubtypic Protection against Pathogenic Human and Avian Influenza Viruses via In Vivo Electroporation of Synthetic Consensus DNA Antigens
por: Laddy, Dominick J., et al.
Publicado: (2008)

Accelerating Coronavirus Disease 2019 Therapeutic Interventions and Vaccines—Selecting Compounds for Clinical Evaluation in Coronavirus Disease 2019 Clinical Trials
por: Buchman, Timothy G., et al.
Publicado: (2021)

The association of remnant cholesterol (RC) and interaction between RC and diabetes on the subsequent risk of hypertension
por: Wang, Jie, et al.
Publicado: (2022)

RC active circuits : theory and design /
por: Bruton, Leonard T.
Publicado: (1980)

Mutations in glycyl-tRNA synthetase impair mitochondrial metabolism in neurons
por: Boczonadi, Veronika, et al.
Publicado: (2018)

R_c Measurements at LEP
por: Baudot, J
Publicado: (1996)

Active RC filter design
por: Herpy, Miklos, et al.
Publicado: (1986)

PaRC users guide
por: Masso, S, et al.
Publicado: (1993)

Drought-Responsive NAC Transcription Factor RcNAC72 Is Recognized by RcABF4, Interacts with RcDREB2A to Enhance Drought Tolerance in Arabidopsis
por: Jia, Xin, et al.
Publicado: (2022)

Incidental inequity
por: Nowak, Kristen J., et al.
Publicado: (2018)

RcSPL1–RcTAF15b regulates the flowering time of rose (Rosa chinensis)
por: Yu, Rui, et al.
Publicado: (2023)

Summary of R_c measurements in DELPHI
por: DELPHI Collaboration
Publicado: (2018)

Summary of R_c measurements in DELPHI
por: Bloch, D, et al.
Publicado: (1996)

Le contrat d'assurance RC
por: Brehm, Roland
Publicado: (1997)

Measurement of Rc at 189 GeV
por: Goy, C
Publicado: (2000)

The collective impact of rare diseases in Western Australia: an estimate using a population-based cohort
por: Walker, Caroline E., et al.
Publicado: (2017)

Seismic design of RC buildings: theory and practice
por: Manohar, Sharad, et al.
Publicado: (2015)

Handbook of operational amplifier active RC networks
por: Burr-Brown Research Corporation
Publicado: (1966)

Beitrage zur Synthese aktiver RC-Netzwerke
por: Schwant, Joachim
Publicado: (1969)

Effects on QCD in $R_b$ and $R_c$
por: Branson, J G
Publicado: (1996)

Summary: $R_b$, $R_c$ and QCD
por: Blondel, A
Publicado: (1996)

Introduction : $R_b$, $R_c$ and QCD
por: Blondel, A
Publicado: (1996)

RC4 stream cipher and its variants
por: Paul, Goutam, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b8qaheqonh2rt63cjq2t5ij0qu